Ladenburg Thalmann Financial Services

In a report published Monday, Ladenburg Thalmann Financial Services reiterated its Buy rating on American States Water Company (NYSE: AWR), and raised its price target from $45.00 to $48.00. Ladenburg Thalmann noted, “AWR continues to trade at a 10% discount to U.S. water utilities on a forward...

In a company update published earlier today, Ladenburg Thalmann Financial Services reiterated its Neutral rating for CMS Energy Corporation (NYSE: CMS) and very slightly raised its price target from $23.00 to $23.50. Ladenburg Thalmann went on to say “We view CMS as a defensive utility investment...

In a report published earlier today, Ladenburg Thalmann Financial Services reiterated its Neutral rating for CMS Energy Corporation (NYSE: CMS) and slightly raised its price target from $23.00 to $23.50. Ladenburg Thalmann went on to say “We view CMS as a defensive utility investment with earnings...

In a company update published earlier today, Ladenburg Thalmann Financial Services reiterated its Buy rating and $7.75 price target for CryoLife, Inc. (NYSE: CRY). Ladenburg Thalmann said in its report “CryoLife expects 2012 revenue from HeRO sales to be between $2.5MM and $3.5MM. The transaction...

In a company update published earlier today, Ladenburg Thalmann Financial Services maintained its Buy rating for BioDelivery Sciences International, Inc. (NASDAQ: BDSI) and slightly raised its price target from $5.00 to $5.50. Ladenburg Thalmann said in its report “BDSI reported EPS of $0.69 for...

In a company update published earlier today, Ladenburg Thalmann Financial Services reiterated its Buy rating for Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) and raised its price target from $28.00 to $33.00. Ladenburg Thalmann went on to say “To be conservative, we have increased our peak sales...

In a company update published earlier today, Ladenburg Thalmann Financial Services maintained its Buy rating for Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) and raised its price target from $15.00 to $17.00. Ladenburg Thalmann said in its report “We believe Dificid [trade name for the antibiotic...

In a company update published earlier today, Ladenburg Thalmann Financial Services reiterated its Buy rating for Copano Energy, LLC (NASDAQ: CPNO) and lowered its price target from $40.00 to $38.00. Ladenburg Thalmann said it made its decisions “to reflect no distribution growth in 2012 and a 5.0...

In a company update published earlier today, Ladenburg Thalmann Financial Services reiterated its Buy rating and $24.00 price target for MAP Pharmaceuticals, Inc. (NASDAQ: MAPP). Ladenburg Thalmann said in its report “We remain positively biased towards Levadex [an inhaled version of the migraine...

Insiders may sell shares for any number of reasons, but there is really only one reason insiders buy shares of a company -- they believe the stock price will move higher and they want to profit from it. Pullbacks and sell-offs provide a perfect opportunity for investors who have faith in a company...